Børge Nordestgaard

Børge Nordestgaard

Clinical Professor

Member of:

  • Clinical Biochemistry


  1. 2019
  2. Published

    Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text

    Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., Tybjærg-Hansen, Anne, Tentolouris, N. & Nordestgaard, Børge, 2019, In: Current Vascular Pharmacology. 17, 5, p. 498-514

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review

    Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., Tybjærg-Hansen, Anne, Tentolouris, N. & Nordestgaard, Børge, 2019, In: Current Vascular Pharmacology. 17, 5, p. 515-537

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement

    Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., Tybjærg-Hansen, Anne, Tentolouris, N. & Nordestgaard, Børge, 2019, In: Current Vascular Pharmacology. 17, 5, p. 538-540

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    Left ventricular hypertrophy identified by cardiac computed tomography and ECG in hypertensive individuals: a population-based study

    Kühl, J. T., Nielsen, J. B., Stisen, Z. R., Fuchs, A., Sigvardsen, P. E., Graff, C., Nordestgaard, Børge, Køber, Lars Valeur & Kofoed, Klaus Fuglsang, 2019, In: Journal of Hypertension. 37, 4, p. 739-746 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Antisense Oligonucleotides Targeting Lipoprotein(a)

    Langsted, A. & Nordestgaard, Børge, 2019, In: Current Atherosclerosis Reports. 21, 8, 7 p., 30.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Elevated Lipoprotein(a) and Risk of Ischemic Stroke

    Langsted, A., Nordestgaard, Børge & Kamstrup, P. R., 2019, In: Journal of the American College of Cardiology. 74, 1, p. 54-66 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    High lipoprotein(a) and high risk of mortality

    Langsted, A., Kamstrup, P. R. & Nordestgaard, Børge, 1 Sep 2019, In: European Heart Journal. 40, 33, p. 2760-2770 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Lipoprotein(a) Should Be Measured in All Individuals Suspected of Having Familial Hypercholesterolemia

    Langsted, A. & Nordestgaard, Børge, Oct 2019, In: Clinical Chemistry. 65, 10, p. 1190-1192

    Research output: Contribution to journalEditorialResearchpeer-review

  10. Published

    Nonfasting versus fasting lipid profile for cardiovascular risk prediction

    Langsted, A. & Nordestgaard, Børge, 2019, In: Pathology. 51, 2, p. 131-141

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Response to 'Lipoprotein(a): It is not the cholesterol content: It is the apolipoprotein(a)!'

    Langsted, A., Kamstrup, P. R. & Nordestgaard, Børge, 2019, In: European Heart Journal. 40, 43, p. 3577 1 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

ID: 11241